Fifth Lane Capital’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,000
Closed -$2.56K 66
2024
Q3
$2.56K Hold
50,000
0.01% 50
2024
Q2
$5.12K Hold
50,000
0.01% 99
2024
Q1
$8.75K Hold
50,000
0.01% 128
2023
Q4
$4.92K Sell
50,000
-50,000
-50% -$5.75K 0.01% 71
2023
Q3
$15.3K Buy
100,000
+50,000
+100% +$6.7K 0.01% 150
2023
Q2
$6.75K Hold
50,000
﹤0.01% 165
2023
Q1
$8.5K Hold
50,000
﹤0.01% 121
2022
Q4
$8.63K Hold
50,000
0.01% 93
2022
Q3
$4K Hold
50,000
﹤0.01% 156
2022
Q2
$5K Hold
50,000
﹤0.01% 272
2022
Q1
$7K Buy
+50,000
New +$8.41K ﹤0.01% 283

Other funds holding NVACR

Fifth Lane Capital's NVACR Position: Q4 2024 in Review

Fifth Lane Capital sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2024, closing a stake of 50,000 shares — an estimated $2.56K sold.

Fifth Lane Capital first reported a position in NVACR in Q1 2022 and held it in 11 quarters. The position peaked at $15.3K in Q3 2023. 5 funds tracked by Wall St. Rank hold NVACR as of Q4 2024.

  • Fifth Lane Capital reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2024 after selling out during the quarter.
  • Fifth Lane Capital sold 50,000 NorthView Acquisition Corporation Rights shares in Q4 2024, an estimated $2.56K.
  • Fifth Lane Capital first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 11 quarters.
  • Fifth Lane Capital's NorthView Acquisition Corporation Rights position peaked at $15.3K in Q3 2023.
  • 5 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2024.

Based on Fifth Lane Capital's 13F filing for Q4 2024, filed 14 Feb 2025.